Diazepam Trial in GAD65 Associated Epilepsy

Clinical trial NCT05361447 · WITHDRAWN

Trial details

NCT number: NCT05361447
Sponsor: Mayo Clinic
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

GAD 65 Antibody-associated Epilepsy

Start date: 2023-01-11
Primary completion: 2024-12-13
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.